TI
AMAG

Turner Investments’s AMAG Pharmaceuticals AMAG Stock Holding History

Turner Investments’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-9,500
Closed -$331K – 293
2016
Q4 		$331K Buy
+9,500
New +$284K 0.13% 183
2015
Q4 		– Sell
-40,910
Closed -$1.63M – 287
2015
Q3 		$1.63M Sell
40,910
-16,820
-29% -$1.04M 0.33% 100
2015
Q2 		$3.99M Sell
57,730
-22,320
-28% -$1.4M 0.73% 46
2015
Q1 		$4.38M Sell
80,050
-8,350
-9% -$398K 0.79% 33
2014
Q4 		$3.77M Sell
88,400
-136,650
-61% -$4.94M 0.45% 50
2014
Q3 		$7.18M Buy
225,050
+80,240
+55% +$1.71M 0.43% 58
2014
Q2 		$3M Buy
+144,810
New +$2.68M 0.13% 211

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Turner Investments's AMAG Position: Q1 2017 in Review

Turner Investments sold out of AMAG Pharmaceuticals (AMAG) in Q1 2017, closing a stake of 9,500 shares — an estimated $331K sold.

Turner Investments first reported a position in AMAG in Q2 2014 and held it in 7 quarters. The position peaked at $7.18M in Q3 2014. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2017.

  • Turner Investments reported no remaining AMAG Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Turner Investments sold 9,500 AMAG Pharmaceuticals shares in Q1 2017, an estimated $331K.
  • Turner Investments first reported a position in AMAG Pharmaceuticals in Q2 2014 and held it in 7 quarters.
  • Turner Investments's AMAG Pharmaceuticals position peaked at $7.18M in Q3 2014.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2017.

Based on Turner Investments's 13F filing for Q1 2017, filed 11 May 2017.